Huntington-kór: vizsgálatok itt: Dánia
4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in DániaA Phase 2, open-label trial to investigate the long-term safety of VO659 administered intrathecally in participants with Huntington’s disease and spinocerebellar ataxia type 1 and 3
- Where
- Copenhagen Oe
- Életkor
- 18 év to 64 év
- People
- 60 worldwide
- Run by
- Vico Therapeutics B.V.
See details and how to join2026-526408-60-00 · EU 2026-526408-60-00 - 3. fázisTaking peopleA Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
- Where
- Copenhagen Oe
- Életkor
- 21 év to 70 év
- People
- 770 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07326709 · EU 2025-522227-99-00 - 1/2. fázisTaking peopleA Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD
- Where
- Copenhagen Oe
- Életkor
- 25 év to 60 év
- People
- 68 worldwide
- Run by
- Vico Therapeutics B. V.
See details and how to joinNCT05822908 · EU 2024-514328-18-00 - No phaseTaking peopleEnroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
- Where
- Aarhus, Copenhagen, Odense
- Életkor
- 18 év and over
- People
- 35 000 worldwide
- Run by
- CHDI Foundation, Inc.
See details and how to joinNCT01574053